Digital phenotyping approaches and mobile devices enhance CNS biopharmaceutical research and development

Relapse prediction in schizophrenia through digital phenotyping: a pilot study

(2018) Ian Barnett et al.   NEUROPSYCHOPHARMACOLOGY

Detection of Motor Impairment in Parkinson's Disease Via Mobile Touchscreen Typing

(2017) Teresa Arroyo-Gallego et al.   IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING

New dimensions and new tools to realize the potential of RDoC: digital phenotyping via smartphones and connected devices

(2017) J Torous et al.   Translational Psychiatry

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

(2016) Brett A. Clementz et al.   AMERICAN JOURNAL OF PSYCHIATRY

Technology in Parkinson's disease: Challenges and opportunities

(2016) Alberto J. Espay et al.   MOVEMENT DISORDERS

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

(2016) Andrew T Drysdale et al.   NATURE MEDICINE

Harnessing Smartphone-Based Digital Phenotyping to Enhance Behavioral and Mental Health

(2016) Jukka-Pekka Onnela et al.   NEUROPSYCHOPHARMACOLOGY

Realizing the Potential of Mobile Mental Health: New Methods for New Data in Psychiatry

(2015) John Torous et al.   Current Psychiatry Reports

Smartphone Ownership and Interest in Mobile Applications to Monitor Symptoms of Mental Health Conditions

(2014) John Torous et al.   JMIR mHealth and uHealth